#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Pemphigus Adrenogenital syndrome Gastrointestinal cancer metastatic Pericarditis Myxoid liposarcoma Leukodystrophy Neuroblastoma Eosinophilic oesophagitis Cardiac arrest Philadelphia positive acute lymphocytic leukaemia Oesophageal achalasia Insulinoma Netherton's syndrome Chronic hepatitis B More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Treatment Noonan syndrome – Diagnostics Breast angiosarcoma – Basic Information Ornithine transcarbamoylase deficiency Basal cell naevus syndrome – Diagnostics Chondrosarcoma – Basic Information Rhabdomyosarcoma – Trials in Disease Aicardi-Goutieres syndrome – Treatment Haemophagocytic lymphohistiocytosis – Treatment Primary immunodeficiency syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    (-)-PHENSERINE TARTRATE GSKVX000000048111 Alfacalcidol Onfekafusp Alfa VERCIRNON Thymalfasin Leriglitazone Glucose Monohydrate Fianlimab Lna043 Phenylalanine Pyridoxine Hydrochloride Voclosporin Hydroxycarbamide Egl-001 Larotrectinib Sulfate Nacubactam Enx-101 Sodium Hydrogen Carbonate Etelcalcetide More therapies…

    Learn about Your Condition

    Breast cancer recurrent Meniscus injury Endometrial stromal sarcoma Intervertebral disc protrusion Hernia repair Dengue fever Thalassaemia beta Procedural headache White matter lesion Thymic carcinoma Immunosuppression Metabolic disorder Follicular lymphoma stage III Metastases to biliary tract Optic ischaemic neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety of Argon and Oxygen Ventilation for Patients Resuscitated from Cardiac Arrest

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Argon
    • Nitrous Oxide
    • Oxygen
    Italy

  • Study on Ketamine for Treating Patients with Severe Brain Injury and Disorders of Consciousness

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Ketamine
    • Sodium Chloride
    Belgium

  • Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to rectum
    • Colorectal cancer
    • Colorectal cancer metastatic
    The Netherlands

  • Study on Fluconazole and Cefalexin Monohydrate for Treating Laryngeal Leukoplakia in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Laryngeal leukoplakia
    Investigated Drugs:
    • Cefalexin Monohydrate
    • Fluconazole
    Finland

  • Study of Atezolizumab with BCG Treatment for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Previously Received BCG

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    Belgium France Spain

  • Study on the Tolerability and Acceptance of Oral Hydrocortisone for Children with Adrenal Hyperplasia or Adrenal Insufficiency

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperplasia adrenal
    • Primary adrenal insufficiency
    Investigated Drugs:
    • Hydrocortisone Ph. Eur.
    Spain
Previous Page
1 … 859 860 861 862 863 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!